Jefferies Keeps Their Buy Rating on West Pharmaceutical Services (WST)
TipRanks (Tue, 13-Jan 10:17 AM ET)
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines
Benzinga (Tue, 13-Jan 8:09 AM ET)
TipRanks (Tue, 13-Jan 3:30 AM ET)
TipRanks (Mon, 12-Jan 2:25 PM ET)
AbbVie to buy Arizona manufacturing facility from West Pharmaceutical
Seeking Alpha News (Mon, 12-Jan 6:09 AM ET)
PRNewswire (Mon, 12-Jan 6:00 AM ET)
PRNewswire (Mon, 12-Jan 6:00 AM ET)
West to Participate in Upcoming Investor Conference
PRNewswire (Fri, 12-Dec 6:00 AM ET)
West Declares Quarterly Dividend
PRNewswire (Wed, 10-Dec 6:00 AM ET)
PRNewswire (Mon, 27-Oct 6:00 AM ET)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs trades on the NYSE stock market under the symbol WST.
As of January 14, 2026, WST stock price climbed to $274.32 with 35,112 million shares trading.
WST has a beta of 0.81, meaning it tends to be less sensitive to market movements. WST has a correlation of 0.07 to the broad based SPY ETF.
WST has a market cap of $19.74 billion. This is considered a Large Cap stock.
Last quarter West Pharmaceutical Servs reported $805 million in Revenue and $1.96 earnings per share. This beat revenue expectation by $18 million and exceeded earnings estimates by $.28.
In the last 3 years, WST traded as high as $415.73 and as low as $187.43.
The top ETF exchange traded funds that WST belongs to (by Net Assets): VTI, VOO, VO, VUG, IVV.
WST has underperformed the market in the last year with a price return of -19.0% while the SPY ETF gained +19.6%. However, in the short term, WST had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.6% vs +4.1% return in SPY. But in the last 2 weeks, WST shares have been beat by the market, returning -0.9% compared to an SPY return of +0.2%.
WST support price is $267.09 and resistance is $276.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WST shares will trade within this expected range on the day.